Logo for Metagenomi Inc

Metagenomi Investor Relations Material

Latest events

Logo for Metagenomi Inc

Study Update

Metagenomi
Logo for Metagenomi

Q4 2024

17 Mar, 2025
Logo for Metagenomi

Q3 2024

13 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Metagenomi Inc

Access all reports
Metagenomi Inc. is a biotechnology firm specializing in genetic medicines through its advanced metagenomics-derived genome editing technologies. The company leverages a proprietary toolbox that includes a variety of programmable nucleases, base editors, and RNA and DNA-mediated integration systems. These tools are designed to create precise and curative genetic therapies. Metagenomi focuses on developing these therapies to treat a range of serious diseases by harnessing naturally evolved microbial systems to enhance genome editing capabilities. The company is headquartered in Emeryville, California, and its shares are listed on the NASDAQ.